Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCSH.L Regulatory News (CSH)

  • There is currently no data for CSH

Analyst Presentation Time Change

25 Nov 2022 07:00

RNS Number : 5671H
Civitas Social Housing PLC
25 November 2022
Ā 

25 November 2022

CIVITAS SOCIAL HOUSING PLC

Analyst Presentation Time Change

As previously announced, Civitas Social Housing PLC (the "Company" or "CSH"), the UK's leading care-based and healthcare REIT,Ā will report results for the six months ended 30 September 2022 on Tuesday 6 December 2022.

However, the live audiocast results presentation for sell-side analysts will now be held at 11.00am on the morning of results.

Ā 

As announced previously, a Q&A facility will also be available on the morning of results and the presentation will be led by Andrew Dawber, Group Director and Paul Bridge, CEO of Social Housing at Civitas Investment Management Limited, the Company's investment adviser.Ā After the event, a recording will also be published on the Company's website.

Ā 

If you would like to attend please RSVP to civitas@buchanan.uk.com.

For further information, please contact:

Ā 

Civitas Investment Management Limited

Andrew Dawber Tel: +44 (0)20 3058 4846

Paul Bridge Tel: +44 (0)20 3058 4844

Ā 

Panmure Gordon

Sapna Shah Tel: +44 (0)20 7886 2783

Tom Scrivens Tel: +44 (0) 20 7886 2648

Ā 

Liberum Capital Tel: +44 (0) 20 3100 2000

Chris Clarke

Darren Vickers

Owen Matthews

Ā 

Buchanan

Helen Tarbet / Henry Wilson Tel: +44 (0) 20 7466 5000

Hannah Ratcliff / Verity Parker civitas@buchanan.uk.com

Ā 

Ā 

Notes:

Civitas Social Housing PLC (CSH) was created in 2016 by Civitas Investment Management Limited as the first dedicated London listed REIT to raise long-term, sustainable, institutional capital to invest in care-based social homes and healthcare facilities across the UK. CSH's portfolio has been independently valued at £968.8million (31 March 2022). CSH now provides homes for 4,594 working age adults with long-term care needs, in 697 bespoke properties that are supported by 130 specialist care providers, 18 approved providers and working with over 178 individual local authority partners.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Ā 
END
Ā 
Ā 
MSCBKQBDDBDBDDB
Date   Source Headline
6th Jun 20177:00 amRNSAcquisition
24th May 20172:34 pmRNSHolding(s) in Company
22nd May 20177:00 amRNSAcquisition
17th May 20174:26 pmRNSAGM Statement
16th May 20177:00 amRNSAcquisition
11th May 201710:09 amRNSAcquisition
5th May 20172:43 pmRNSAcquisition
4th May 20177:00 amRNSNet Asset Value and Dividend Declaration
2nd May 20177:00 amRNSAcquisition
24th Apr 20177:00 amRNSAcquisition
18th Apr 201712:00 pmRNSAcquisition
10th Apr 20171:54 pmRNSHolding(s) in Company
10th Apr 20177:00 amRNSNotice of AGM
5th Apr 20177:00 amRNSUpdate since IPO & Analyst Meeting
3rd Apr 20177:00 amRNSAcquisition
10th Mar 20177:00 amRNSAcquisition
8th Feb 20177:00 amRNSNet Asset Value(s)
1st Feb 20175:56 pmRNSHolding(s) in Company
27th Jan 20172:37 pmRNSHolding(s) in Company
23rd Dec 20167:00 amRNSAcquisition
15th Dec 20167:00 amRNSAcquisition
13th Dec 20164:20 pmRNSHolding(s) in Company
8th Dec 20166:25 pmRNSHolding(s) in Company
28th Nov 20165:05 pmRNSHolding(s) in Company
23rd Nov 20165:30 pmRNSHolding(s) in Company
18th Nov 20163:08 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.